Xiao Ming Yang (Xiaoming Yang, Xiao-Ming Yang)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 56

Top Venues

Vaccines

Nature immunology

Signal transduction and targeted therapy

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan, Xiao Ming Yang
Correction: Nian et al. Coping Strategies for Pertussis Resurgence. Vaccines 2023, 11 , 889. Vaccines 12 (2) (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology 25 (2) (2024)
Fang Li, Bo Liu, Yu Xiong, Zhegang Zhang, Qingmei Zhang, Ran Qiu, Feixia Peng, Xuanxuan Nian, Dongping Wu, Xuedan Li, Jing Liu, Ze Li, Hao Tu, Wenyi Wu, Yu Wang, Jiayou Zhang, Xiao Ming Yang
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine. Vaccines 12 (2) (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Publisher Correction: Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against monkeypox virus. Nature immunology (2024)
Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan, Xiao Ming Yang
Correction: Nian et al. Coping Strategies for Pertussis Resurgence. Vaccines 2023, 11 , 889. Vaccines 12 (2) (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology 25 (2) (2024)
Fang Li, Bo Liu, Yu Xiong, Zhegang Zhang, Qingmei Zhang, Ran Qiu, Feixia Peng, Xuanxuan Nian, Dongping Wu, Xuedan Li, Jing Liu, Ze Li, Hao Tu, Wenyi Wu, Yu Wang, Jiayou Zhang, Xiao Ming Yang
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine. Vaccines 12 (2) (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Publisher Correction: Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology 25 (2) (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology 25 (2) (2024)
Han Wang, Peng Yin, Tingting Zheng, Lanju Qin, Shihua Li, Pu Han, Xiao Qu, Jun Wen, Haoyi Ding, Jiahao Wu, Tianxiang Kong, Zhengrong Gao, Songtao Hu, Xin Zhao, Xiangyu Cao, Min Fang, Jianxun Qi, Jianzhong Jeff Xi, Kai Duan, Xiao Ming Yang, Zhuobing Zhang, Qihui Wang, Wenjie Tan, George Fu Gao
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus. Nature immunology (2024)
Nawal Al Kaabi, Yunkai Yang, Salah Eldin Hussein, Tian Yang, Jehad Abdalla, Hui Wang, Zhiyong Lou, null Chinese Center For Disease Control And Prevention, Agyad Bakkour, Afnan Arafat, null China National Biotec Group Company Limited, Zhiwei Jiang, Ye Tian, null National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd, null Beijing Institute Of Biological Products Company Limited, Peng Xiao, Walid Zaher, Islam Eltantawy, Chenlong Wang, Guangxue Xu, Yuntao Zhang, Xiao Ming Yang
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi. Vaccines 11 (2) (2023)
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Z Abbas, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial. Signal transduction and targeted therapy 8 (1) (2023)
Yu Guo, Guangshun Zhang, Qi Yang, Xiaowei Xie, Yang Lu, Xuelian Cheng, Hui Wang, Jingxi Liang, Jielin Tang, Yuxin Gao, Hang Shang, Jun Dai, Yongxia Shi, Jiaxi Zhou, Jun Zhou, Hangtian Guo, Haitao Yang, Jianwei Qi, Lijun Liu, Shihui Ma, Biao Zhang, Qianyu Huo, Yi Xie, Junping Wu, Fang Dong, Song Zhang, Zhiyong Lou, Yan Gao, Zidan Song, Wenming Wang, Zixian Sun, Xiao Ming Yang, Dongsheng Xiong, Fengjiang Liu, Xinwen Chen, Caiying Zhu, Ximo Wang, Tao Cheng, Zihe Rao
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. Nature communications 14 (1) (2023)
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Z Abbas, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial. Signal transduction and targeted therapy 8 (1) (2023)
Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan, Xiao Ming Yang
Coping Strategies for Pertussis Resurgence. Vaccines 11 (5) (2023)
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Z Abbas, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial. Signal transduction and targeted therapy 8 (1) (2023)
Jiaji Li, Jinrong Shi, Zhijun Zhou, Bo Yang, Jiamin Cao, Zhongsen Cao, Qiang Zeng, Zheng Hu, Xiao Ming Yang
Development of an Antigen Detection Kit Capable of Discriminating the Omicron Mutants of SARS-CoV-2. Vaccines 11 (2) (2023)
Xuedan Li, Yang Le, Zhegang Zhang, Xuanxuan Nian, Bo Liu, Xiao Ming Yang
Viral Vector-Based Gene Therapy. International journal of molecular sciences 24 (9) (2023)
Nawal Al Kaabi, Yunkai Yang, Salah Eldin Hussein, Tian Yang, Jehad Abdalla, Hui Wang, Zhiyong Lou, null Chinese Center For Disease Control And Prevention, Agyad Bakkour, Afnan Arafat, null China National Biotec Group Company Limited, Zhiwei Jiang, Ye Tian, null National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd, null Beijing Institute Of Biological Products Company Limited, Peng Xiao, Walid Zaher, Islam Eltantawy, Chenlong Wang, Guangxue Xu, Yuntao Zhang, Xiao Ming Yang
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi. Vaccines 11 (2) (2023)
Xuedan Li, Yang Le, Zhegang Zhang, Xuanxuan Nian, Bo Liu, Xiao Ming Yang
Viral Vector-Based Gene Therapy. International journal of molecular sciences 24 (9) (2023)
Junzheng Wu, Huichuan Yang, Ding Yu, Xiao Ming Yang
Blood-derived product therapies for SARS-CoV-2 infection and long COVID. MedComm 4 (6) (2023)
Fujun Hou, Yuntao Zhang, Xiaohu Liu, Yanal M Murad, Jiang Xu, Zhibin Yu, Xianwu Hua, Yingying Song, Jun Ding, Hongwei Huang, Ronghua Zhao, William Wei-Guo Jia, Xiao Ming Yang
mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nature communications 14 (1) (2023)
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Z Abbas, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial. Signal transduction and targeted therapy 8 (1) (2023)
Yanhui Xiao, Xue Guo, Min Zhang, Yaping Chen, Yanyang Zhang, Xiaoqing Yu, Linyun Luo, Haiping Chen, Weichai Xu, Haibo Liu, Lixia Wu, Renwu Hou, Yong Ma, Lin Long, Jiewei Ruan, Wei Chen, Xiao Ming Yang
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial. Vaccines 11 (4) (2023)
Shouzhi Yu, Yangyang Wei, Hongyang Liang, Wenheng Ji, Zhen Chang, Siman Xie, Yichuan Wang, Wanli Li, Yingwei Liu, Hao Wu, Jie Li, Hui Wang, Xiao Ming Yang
Correction: Yu et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses 2022, 14 , 1938. Viruses 15 (5) (2023)
Jinrong Shi, Ailin Shen, Yao Cheng, Chi Zhang, Xiao Ming Yang
30-Year Development of Inactivated Virus Vaccine in China. Pharmaceutics 15 (12) (2023)
Baifeng Yang, Dewu Zhu, Yisi Zhou, Beizhe Gong, Yuan Hu, Jiayou Zhang, Shihe Huang, Xuanxuan Nian, Xinghang Li, Xinguo Li, Kai Duan, Xiao Ming Yang
Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model. Vaccines 11 (5) (2023)
Jinrong Shi, Ailin Shen, Yao Cheng, Chi Zhang, Xiao Ming Yang
30-Year Development of Inactivated Virus Vaccine in China. Pharmaceutics 15 (12) (2023)
Jiaji Li, Jinrong Shi, Zhijun Zhou, Bo Yang, Jiamin Cao, Zhongsen Cao, Qiang Zeng, Zheng Hu, Xiao Ming Yang
Development of an Antigen Detection Kit Capable of Discriminating the Omicron Mutants of SARS-CoV-2. Vaccines 11 (2) (2023)
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Z Abbas, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial. Signal transduction and targeted therapy 8 (1) (2023)
Bopei Cui, Lifang Song, Qian Wang, Kelei Li, Qian He, Xing Wu, Fan Gao, Mingchen Liu, Chaoqiang An, Qiushuang Gao, Chaoying Hu, Xiaotian Hao, Fangyu Dong, Jiuyue Zhou, Dong Liu, Ziyang Song, Xujia Yan, Jialu Zhang, Yu Bai, Qunying Mao, Xiao Ming Yang, Zhenglun Liang
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors. Signal transduction and targeted therapy 8 (1) (2023)
Yanhui Xiao, Xue Guo, Min Zhang, Yaping Chen, Yanyang Zhang, Xiaoqing Yu, Linyun Luo, Haiping Chen, Weichai Xu, Haibo Liu, Lixia Wu, Renwu Hou, Yong Ma, Lin Long, Jiewei Ruan, Wei Chen, Xiao Ming Yang
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial. Vaccines 11 (4) (2023)
Yanhui Xiao, Xue Guo, Min Zhang, Yaping Chen, Yanyang Zhang, Xiaoqing Yu, Linyun Luo, Haiping Chen, Weichai Xu, Haibo Liu, Lixia Wu, Renwu Hou, Yong Ma, Lin Long, Jiewei Ruan, Wei Chen, Xiao Ming Yang
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial. Vaccines 11 (4) (2023)
Nawal Al Kaabi, Yun Kai Yang, Jing Zhang, Ke Xu, Yu Liang, Yun Kang, Ji Guo Su, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Shuai Shao, Sen Sen Yang, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Ning Liu, Fu Jie Shen, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial. Signal transduction and targeted therapy 7 (1) (2022)
Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu, Deming Ji, Ran Qiu, Lianzhen Lin, Yan Zeng, Fei Xia, Yong Hu, Taojing Li, Kai Duan, Xinguo Li, Zejun Wang, Yong Zhang, Hang Zhang, Chen Zhu, Shang Wang, Xiao Wu, Xiang Wang, Yuwei Li, Shihe Huang, Min Mao, Huanhuan Guo, Yunkai Yang, Rui Jia, Jingwei Xufang, Xuewei Wang, Shuyan Liang, Zhixin Qiu, Juan Zhang, Yaling Ding, Chunyan Li, Jin Zhang, Daoxing Fu, Yanlin He, Dongbo Zhou, Cesheng Li, Jiayou Zhang, Ding Yu, Xiao Ming Yang
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan. Cell discovery 8 (1) (2022)
Xiaoman Li, Yongbing Pan, Qiangling Yin, Zejun Wang, Sisi Shan, Laixing Zhang, Jinfang Yu, Yuanyuan Qu, Lina Sun, Fang Gui, Jia Lu, Zhaofei Jing, Wei Wu, Tao Huang, Xuanling Shi, Jiandong Li, Xinguo Li, Dexin Li, Shiwen Wang, Maojun Yang, Linqi Zhang, Kai Duan, Mifang Liang, Xiao Ming Yang, Xinquan Wang
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages. Cell discovery 8 (1) (2022)
Shouzhi Yu, Yunchao Huang, Chongyang Wu, Weibin Fu, Hongyang Liang, Chen Chen, Yue Cheng, Yancen Guo, Ying Zhang, Hui Wang, Xiao Ming Yang
Integrated Multi-Omic Characterization of the Detachment Process of Adherent Vero Cells with Animal-Based and Animal-Origin-Free Enzymes. Cells 11 (21) (2022)
Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu, Deming Ji, Ran Qiu, Lianzhen Lin, Yan Zeng, Fei Xia, Yong Hu, Taojing Li, Kai Duan, Xinguo Li, Zejun Wang, Yong Zhang, Hang Zhang, Chen Zhu, Shang Wang, Xiao Wu, Xiang Wang, Yuwei Li, Shihe Huang, Min Mao, Huanhuan Guo, Yunkai Yang, Rui Jia, Jingwei Xufang, Xuewei Wang, Shuyan Liang, Zhixin Qiu, Juan Zhang, Yaling Ding, Chunyan Li, Jin Zhang, Daoxing Fu, Yanlin He, Dongbo Zhou, Cesheng Li, Jiayou Zhang, Ding Yu, Xiao Ming Yang
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan. Cell discovery 8 (1) (2022)
Nawal Al Kaabi, Yun Kai Yang, Li Fang Du, Ke Xu, Shuai Shao, Yu Liang, Yun Kang, Ji Guo Su, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Sen Sen Yang, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Xiangfeng Cong, Yao Tan, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Z Abbas, Sally A Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Jun Wei Hou, Ze Hua Lei, Peng Xiao, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial. Nature communications 13 (1) (2022)
Zilin Qiao, Yuejiao Liao, Mengyuan Pei, Zhenyu Qiu, Zhenbin Liu, Dongwu Jin, Jiayou Zhang, Zhongren Ma, Xiao Ming Yang
RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells. Viruses 14 (11) (2022)
Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu, Deming Ji, Ran Qiu, Lianzhen Lin, Yan Zeng, Fei Xia, Yong Hu, Taojing Li, Kai Duan, Xinguo Li, Zejun Wang, Yong Zhang, Hang Zhang, Chen Zhu, Shang Wang, Xiao Wu, Xiang Wang, Yuwei Li, Shihe Huang, Min Mao, Huanhuan Guo, Yunkai Yang, Rui Jia, Jingwei Xufang, Xuewei Wang, Shuyan Liang, Zhixin Qiu, Juan Zhang, Yaling Ding, Chunyan Li, Jin Zhang, Daoxing Fu, Yanlin He, Dongbo Zhou, Cesheng Li, Jiayou Zhang, Ding Yu, Xiao Ming Yang
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan. Cell discovery 8 (1) (2022)
Jiayou Zhang, Xuanxuan Nian, Xuedan Li, Shihe Huang, Kai Duan, Xinguo Li, Xiao Ming Yang
The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review. Vaccines 10 (11) (2022)
Shouzhi Yu, Yao He, Wenheng Ji, Rong Yang, Yuxiu Zhao, Yan Li, Yingwei Liu, Ling Ding, Meng Ma, Hui Wang, Xiao Ming Yang
Metabolic and Proteomic Profiles Associated with Immune Responses Induced by Different Inactivated SARS-CoV-2 Vaccine Candidates. International journal of molecular sciences 23 (18) (2022)
Xuanxuan Nian, Jiayou Zhang, Shihe Huang, Kai Duan, Xinguo Li, Xiao Ming Yang
Development of Nasal Vaccines and the Associated Challenges. Pharmaceutics 14 (10) (2022)
Shouzhi Yu, Junyu Yan, Zhaona Yang, Yuxiu Zhao, Hui Wang, Xiao Ming Yang
Metabolic Responses and Pathway Changes of Vero Cells under High-Vitamin B Medium. Vaccines 10 (11) (2022)
Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, Zhijun Zhou, Yong Xie, Taojing Li, Junzheng Wu, Fengping Lu, Lu Feng, Min Mao, Lianzhen Lin, Huanhuan Guo, Shenglan Yue, Feifei Wang, Yan Peng, Yong Hu, Zejun Wang, Jianhong Yu, Yong Zhang, Jia Lu, Haoran Ning, Huichuan Yang, Daoxing Fu, Yanlin He, Dongbo Zhou, Tao Du, Kai Duan, Demei Dong, Kun Deng, Xia Zou, Ya Zhang, Rong Zhou, Yang Gao, Xinxin Zhang, Xiao Ming Yang
Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nature communications 12 (1) (2021)
Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, Zhijun Zhou, Yong Xie, Taojing Li, Junzheng Wu, Fengping Lu, Lu Feng, Min Mao, Lianzhen Lin, Huanhuan Guo, Shenglan Yue, Feifei Wang, Yan Peng, Yong Hu, Zejun Wang, Jianhong Yu, Yong Zhang, Jia Lu, Haoran Ning, Huichuan Yang, Daoxing Fu, Yanlin He, Dongbo Zhou, Tao Du, Kai Duan, Demei Dong, Kun Deng, Xia Zou, Ya Zhang, Rong Zhou, Yang Gao, Xinxin Zhang, Xiao Ming Yang
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nature communications 12 (1) (2021)
Yongbing Pan, Jianhui Du, Jia Liu, Hai Wu, Fang Gui, Nan Zhang, Xiaojie Deng, Gang Song, Yufeng Li, Jia Lu, Xiaoli Wu, ShanShan Zhan, Zhaofei Jing, Jiong Wang, Yimin Yang, Jianbang Liu, Ying Chen, Qin Chen, Huanyu Zhang, Hengrui Hu, Kai Duan, Man-Li Wang, Qisheng Wang, Xiao Ming Yang
Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries. Cell discovery 7 (1) (2021)
Ming-Liang Ma, Da-Wei Shi, Yang Li, Wei Hong, Dan-Yun Lai, Jun-Biao Xue, He-Wei Jiang, Hai-Nan Zhang, Huan Qi, Qing-Feng Meng, Shu-Juan Guo, De-Ju Xia, Jin-Jun Hu, Shuo Liu, He-Yang Li, Jie Zhou, Wei Wang, Xiao Yang, Xiong-Lin Fan, Qing Lei, Wei-Jun Chen, Ce-Sheng Li, Xiao Ming Yang, Si-Hong Xu, Hong-Ping Wei, Sheng-Ce Tao
Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy. Cell discovery 7 (1) (2021)
Kai Duan, Bende Liu, Cesheng Li, Huajun Zhang, Ting Yu, Jie-Ming Qu, Min Zhou, Li Chen, Zhu Chen, Xinxin Zhang, Xiao Ming Yang
Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19. Proceedings of the National Academy of Sciences of the United States of America 117 (23) (2020)
Junqing Sun, Congcong Liu, Ruchao Peng, Fu-Kun Zhang, Zhou Tong, Sheng Liu, Yi Shi, Zhennan Zhao, Wen-Bo Zeng, George Fu Gao, Hong-Jie Shen, Xiao Ming Yang, Min-Hua Luo, Jianxun Qi, Peiyi Wang
Cryo-EM structure of the varicella-zoster virus A-capsid. Nature communications 11 (1) (2020)
Kai Duan, Bende Liu, Cesheng Li, Huajun Zhang, Ting Yu, Jie-Ming Qu, Min Zhou, Li Chen, Shengli Meng, Yong Hu, Cheng Peng, Mingchao Yuan, Jin Yan Huang, Zejun Wang, Jianhong Yu, Xiaoxiao Gao, Dan Wang, Xiaoqi Yu, Li Li, Jiayou Zhang, Xiao Wu, Bei Li, Yanping Xu, Wei Chen, Yan Peng, Yeqin Hu, Lianzhen Lin, Xuefei Liu, Shihe Huang, Zhijun Zhou, Lianghao Zhang, Yue Wang, Zhi Zhang, Kun Deng, Zhiwu Xia, Qin Gong, Wei Zhang, Xiaobei Zheng, Ying Liu, Huichuan Yang, Dongbo Zhou, Ding Yu, Jifeng Hou, Zhengli Shi, Saijuan Chen, Zhu Chen, Xinxin Zhang, Xiao Ming Yang
Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences of the United States of America 117 (17) (2020)

Xiao Ming Yang.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaoming Yang, Xiao-Ming Yang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao Ming Yang (Xiaoming Yang, Xiao-Ming Yang)